Skip to main content

Find Clinical Trials

Home
Conditions
EGFR-TKI-resistant Non-small Cell Lung Cancer With Leptomeningeal Metastasis

Clinical trial condition

EGFR-TKI-resistant Non-small Cell Lung Cancer With Leptomeningeal Metastasis

Explore clinical trials studying EGFR-TKI-resistant Non-small Cell Lung Cancer With Leptomeningeal Metastasis. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

EGFR-TKI-resistant Non-small Cell Lung Cancer With Leptomeningeal Metastasis trial results

Not Yet Recruiting

Safety and Efficacy of Intrathecal Sacituzumab Tirumotecan for Leptomeningeal Metastasis in EGFR-TKI-Resistant Non-Small Cell Lung Cancer

NCT07702305

Conditions: Central Nervous System Neoplasms, EGFR-TKI-resistant Non-small Cell Lung Cancer With Leptomeningeal Metastasis, Meningeal Carcinomatosis, +5 more
Locations: Not specified

View Trial Details